Jeff Morris

AMMG is excited to announce the launch of its newest online educational module, Exosomes: The Next Generation of Biologic Medicine. Like the highly successful online module on the use of Peptides and Peptide Therapies, this course is a focused track that explores the evidence-based science behind Exosomes and their use in a variety of areas in clinical Age Management Medicine.

Exosomes are tiny, subcellular, membrane-bound vesicles that are released by a wide variety of cell types and cancer cells and that can carry membrane and cellular proteins, as well as DNA, microRNA (miRNA), and various other types of RNA, including mRNA fragments, representative of the cell of origin.

The use of Exosomes has experienced exponential growth over the past 5-10 years. Their uses range from impacting pain management, cardiovascular disease, autoimmune disease, neurodegenerative conditions, and cancer therapeutics, to treatments for conditions of aging such as aesthetics, hair restoration, orthopedics and sexual function.  This course explores the varied uses of Exosomes, including as biomarkers, as ways of treating disease, and as targeted delivery vehicles for therapeutic molecules.

“This course is another example of AMMG’s commitment to fulfill our educational mandate, filling in knowledge gaps for physicians and other healthcare professionals,” said Director of Education, Greg Fillmore.

The comprehensive curriculum includes:

Exosomes: A Primer
Exosomes & Cardiovascular Disease
Exosome Therapy for the Treatment of Encephalitis and Autistic Spectrum Disorders
Exosome Therapy for Erectile Dysfunction
Exosome Therapy in Combination with Laser Ablation for Prostate Cancer Surgery
Regenerative Medicine 101: Exosomes and Stem Cells
Treating “Untreatable” Retinal and Optic Nerve Conditions – The Stem Cell Ophthalmology Treatment Studies
Exosomes and Cancer
Exosomes as a Novel Therapeutic Approach in Gastrointestinal Diseases
Exosome Related Age Management Medicine Clinical Cases
Exosomes: Current Clinical Applications and Future Directions
Point / Counterpoint: Exosomes vs. Stem Cells

There is also a bonus, non-CME lecture on Clinical Experience Using Cell Therapy Derived From Placental Cells.

The distinguished faculty, chosen for their expertise in and familiarity with this cutting-edge knowledge area, are familiar to AMMG conference attendees. They include Ian White, Ph.D.; Kathy O’Neil-Smith, M.D., FAARM; George Shapiro, M.D.; Marvin Sponaugle, M.D.; Paul Thompson, M.D.; Daniel Sperling, M.D.; Jeffrey Weiss, M.D.; Edwin N. Lee, M.D., FACE; Rebecca Murray, APRN, FNP-BC, CDE; Michale “Mickey” Barber, M.D.; William Kapp III, M.D., MS, FAAOS; and Robert Hariri, M.D., Ph.D.

The recorded lectures were previously accredited live presentations at AMMG events.

For more information, go to https://agemed.org/online-cme/